Health Condition 1: R509- Fever, unspecified
Conditions
Interventions
Intervention1: Cap Mubarak: 2 Cap of 500 mg to be taken orally twice daily with water for 3 days
Control Intervention1: Tab Paracetamol: 1 Tab of 500 mg to be taken orally twice daily with water for
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants of either sex in the age group 18 to 65 years. 2. History of onset of fever within 24 hr. 3. Participants with oral temperature 100 F- 102 F presenting with any of the following symptoms: Fever Headache Body ache Joints pain Shivering Chills Palpitation Skin Flushing
Exclusion criteria
Exclusion criteria: 1. Intake of any antipyretic drugs in the previous 8 hrs. 2. Participant having oral temperature of greater than 102 F. 3. Known high risk clinical conditions such as pneumonia, sepsis, dengue haemorrhagic fever,meningitis, hepatitis B, etc. 4. Known cases of Immuno-compromised clinical conditions such as HIV, cancer etc. 5. Known cases of other clinically significant co-morbid conditions (severe hepatic, renal, cardiovascular disorders, etc.) that in the opinion of the investigator could affect the efficacy and safety outcome of the study. 6. Thrombocytopenia i.e. absolute platelet count below 1,00,000. 7. Known hypersensitivity to study drug or any of its ingredients. 8. Pregnant and Lactating females. 9. Diabetes Mellitus or any systemic disorder requiring prolonged treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drug in the treatment of Humma (fever) will be assessed on the basis of reduction in the symptoms and change in temperature from baseline to end of the study and the achievement of defervescence,Timepoint: At baseline and on 3rd day | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and end of treatment i.e. 3rd day. | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed